Cargando…

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis

Individuals with Dupuytren disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an increasingly common and disabling fibroproliferative disorder of the palmar fascia, which leads to flexion contractures of the digits, and is associated with other tissue-specif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Michael, Thakkar, Dipti, Southam, Lorraine, Werker, Paul, Ophoff, Roel, Becker, Kerstin, Nothnagel, Michael, Franke, Andre, Nürnberg, Peter, Espirito-Santo, Ana Isabel, Izadi, David, Hennies, Hans Christian, Nanchahal, Jagdeep, Zeggini, Eleftheria, Furniss, Dominic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591021/ https://www.ncbi.nlm.nih.gov/pubmed/28886342 http://dx.doi.org/10.1016/j.ajhg.2017.08.006

Ejemplares similares

Recent advances in the understanding of Dupuytren’s disease
por: Layton, Thomas, et al.
Publicado: (2019)

Systematic review of non-surgical treatments for early dupuytren’s disease
por: Ball, Catherine, et al.
Publicado: (2016)

Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren’s Disease
por: Becker, Kerstin, et al.
Publicado: (2016)

Treatments for early-stage Dupuytren’s disease: an evidence-based approach
por: Nanchahal, Jagdeep, et al.
Publicado: (2023)

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI
por: Major, Megan, et al.
Publicado: (2019)

Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice
por: Ball, Catherine, et al.
Publicado: (2013)

Dupuytren’s disease is a work-related disorder: results of a population-based cohort study
por: van den Berge, Bente A., et al.
Publicado: (2023)

What do we know about managing Dupuytren’s disease cost-effectively?
por: Dritsaki, Melina, et al.
Publicado: (2018)

A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren’s Disease
por: Riesmeijer, Sophie A., et al.
Publicado: (2019)

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
por: Png, May Ee, et al.
Publicado: (2019)

Imaging for Dupuytren disease: a systematic review of the literature
por: Molenkamp, Sanne, et al.
Publicado: (2019)

Anti-tumour necrosis factor therapy for early-stage Dupuytren’s disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
por: Nanchahal, Jagdeep, et al.
Publicado: (2022)

Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease: an economic evaluation based on a randomized controlled trial and individual-patient simulation model
por: Dakin, Helen, et al.
Publicado: (2022)

Pathways to understanding the genomic aetiology of osteoarthritis
por: Cibrián Uhalte, Elena, et al.
Publicado: (2017)

Dupuytren’s disease: using needles more across the world
por: Warwick, David, et al.
Publicado: (2021)

Matrix and cell phenotype differences in Dupuytren’s disease
por: van Beuge, Marike M., et al.
Publicado: (2016)

Echogenicity of Dupuytren’s nodules is correlated to myofibroblast load and nodule hardness
por: Molenkamp, Sanne, et al.
Publicado: (2021)

The association of bariatric surgery and Dupuytren’s disease: a propensity score-matched cohort study
por: Burkard, Theresa, et al.
Publicado: (2021)

Further evidence of the involvement of the Wnt signaling pathway in Dupuytren’s disease
por: ten Dam, Evert-Jan P. M., et al.
Publicado: (2015)

Dupuytren’s Disease Predicts Increased All-Cause and Cancer-Specific Mortality: Analysis of a Large Cohort from the U.K. Clinical Practice Research Datalink
por: Kuo, Rachel Yi Ling, et al.
Publicado: (2020)

Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis
por: Broekstra, Dieuwke C., et al.
Publicado: (2022)

Patient-Perceived Hand Function Can Predict Treatment for Dupuytren Disease
por: van den Berge, Bente A., et al.
Publicado: (2023)

Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants
por: Riesmeijer, Sophie A., et al.
Publicado: (2019)

A vasculature niche orchestrates stromal cell phenotype through PDGF signaling: Importance in human fibrotic disease
por: Layton, Thomas B., et al.
Publicado: (2022)

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis
por: Izadi, David, et al.
Publicado: (2019)

Replication of Established Common Genetic Variants for Adult BMI and Childhood Obesity in Greek Adolescents: The TEENAGE Study
por: Ntalla, Ioanna, et al.
Publicado: (2013)

Very low-depth sequencing in a founder population identifies a cardioprotective APOC3 signal missed by genome-wide imputation
por: Gilly, Arthur, et al.
Publicado: (2016)

Dupuytren's Contracture
por: Sood, Aditya, et al.
Publicado: (2013)

Dupuytren's contracture
por: Raina, Sujeet, et al.
Publicado: (2012)

Dutch Multidisciplinary Guideline on Dupuytren Disease
por: Kemler, Marius A., et al.
Publicado: (2022)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
por: Puerta Cavanzo, Nataly, et al.
Publicado: (2022)

Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to G(Alert)
por: Lee, Geoffrey, et al.
Publicado: (2018)

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial
por: Nanchahal, Jagdeep, et al.
Publicado: (2018)

Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren’s disease, with an embedded dose response study.
por: Nanchahal, Jagdeep, et al.
Publicado: (2017)

A Systematic Review and Meta-Analysis on the Strength and Consistency of the Associations between Dupuytren Disease and Diabetes Mellitus, Liver Disease, and Epilepsy
por: Broekstra, Dieuwke C., et al.
Publicado: (2018)

Paediatric Dupuytren's disease
por: Korambayil, Pradeoth Mukundan, et al.
Publicado: (2011)

Dupuytren's Treatment of Scrofula
Publicado: (1830)

Dupuytren's Contraction and Dysparathyreoidism
Publicado: (1932)

Dupuytren’s Contraction of the Fingers
Publicado: (1882)

Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states
por: Layton, Thomas B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b7chi3fcashpb12jh66j0ooq8i